Back

Gut microbiome-derived metabolites as prognostic biomarkers in heart failure: a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Prognostic assessment in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor David Koeckerling

University Hospital Heidelberg, Heidelberg (Germany)

7 More presentations in this session

Presentation thumbnail
Deep learning-based prediction of cardiac blood biomarkers from echocardiograms improves prognosis
Ms A. Romano Martinez (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Prevalence and incidence of heart failure in Hungary stratified by age and sex: data from the Hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)
Professor R. Sepp (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
The PREVENT equations predict clinical outcomes in heart failure with preserved ejection fraction.
Doctor K. Iwakura (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic value of the geriatric nutritional risk index in hospitalized heart failure patients
Doctor Z. Nezami (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Evolution and prognostic value of right ventricular to pulmonary artery coupling during guidelines directed medical therapy up-titration
Doctor C. Fauvel (Rouen, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostic assessment in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The independent factors associated with myocardial extracellular volume fraction in acute decompensated heart failure patients
thumbnail
Congress Presentation
Unraveling the choline pathway in heart failure risk and outcomes: a systematic review and meta-analysis
thumbnail
Congress Presentation
Interaction of gut microbiota-derived metabolites with inflammatory markers and cellular rejection in advanced heart failure patients treated with heart transplantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources